---
document_datetime: 2023-09-21 19:40:15
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/imnovid-epar-all-authorised-presentations_en.pdf
document_name: imnovid-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.1924527
conversion_datetime: 2025-12-28 18:32:49.258409
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Pack size   |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|-------------|
| EU/1/13/850/001  | Imnovid           | 1 mg       | Capsule, hard         | Oral use                  | blister (PVC/PCTFE)   | 21 capsules |
| EU/1/13/850/002  | Imnovid           | 2 mg       | Capsule, hard         | Oral use                  | blister (PVC/PCTFE)   | 21 capsules |
| EU/1/13/850/003  | Imnovid           | 3 mg       | Capsule, hard         | Oral use                  | blister (PVC/PCTFE)   | 21 capsules |
| EU1/13/850/004   | Imnovid           | 4 mg       | Capsule, hard         | Oral use                  | blister (PVC/PCTFE)   | 21 capsules |
| EU/1/13/850/005  | Imnovid           | 1 mg       | Capsule, hard         | Oral use                  | blister (PVC/PCTFE)   | 14 capsules |
| EU/1/13/850/006  | Imnovid           | 2 mg       | Capsule, hard         | Oral use                  | blister (PVC/PCTFE)   | 14 capsules |
| EU/1/13/850/007  | Imnovid           | 3 mg       | Capsule, hard         | Oral use                  | blister (PVC/PCTFE)   | 14 capsules |
| EU/1/13/850/008  | Imnovid           | 4 mg       | Capsule, hard         | Oral use                  | blister (PVC/PCTFE)   | 14 capsules |